somat inactiv ptprj mutat dysregul pathway identifi canin malign melanoma integr compar genom william victoria karthigayini christoph kelsey waibhav niev jeffrey winni valeri mitchel alison roe nichola megan jessica mark matthew nichola kevin dougla gerald chand barbara matthew alexand jeffrey integr genom divis translat genom institut tgen phoenix arizona unit state biomed informat arizona state phoenix arizona unit state biomed scienc veterinari north carolina state raleigh unit state dermatolog mayo clinic scottsdal arizona unit state life scienc arizona state phoenix arizona unit state dermatolog queensland queensland diamantina institut translat institut woolloongabba queensland veterinari labouratori california davi davi california unit state labouratori development andel institut vari grand rapid michigan unit state spectrum grand rapid michigan unit state programmem canin genom andel institut vari grand rapid michigan unit state neurogenom divis translat genom institut tgen phoenix arizona unit state oncogenom labouratori qimr berghof institut herstonn brisban queensland divis epidemiolog nation institut nation institut bethesda maryland unit state flint anim colourado state fort collin colourado unit state veterinari norwalk connecticut unit state innogen inc harvard massachusett unit state compar institut north carolina state raleigh unit state author contribut equal jtrent tgen canin malign melanoma signific caus mortal domest dog power compar model human melanoma littl genet aetiolog map genom landscap canin melanoma multiplatform tumour mucos acral cutan uveal match constitut sam ples includ shortinsert whole sequenc rna sequenc array compar genom hybrid singl nucleotid polymorph array target sanger sequenc analys identifi predomin truncat mutat putat tumour suppressor ptprj case braf mutat detect activ ras mutat case occur conserv hotspot cutan acral mucos subtyp amplif open citat hendrick wpd zismann sivaprakasam legendr poorman temb somat inactiv ptprj mutat dysregul pathway identifi canin malign melanoma integr compar genom plos genet https pgen gregori cooper hudsonalpha institut biotechnolog unit state publish copyright open free copyright freeli reproduc distribut transmit modifi built otherwis use anyon law purpos made creativ common domain dedic data avail statement next generat sequenc data submit ncbi biosampl databas ncbi nlm nih gov bioproject project number sampl access plos https pgen compar genom canin malign melanoma mutat mutual exclus addit lowfrequ recurr alter amidst low point mutat rate absenc ultraviolet light mutat signatur abund number structur alter mutat modul prolifer cycl control common highlight therapeut axe mek inhibit mutat landscap resembl braf wildtyp sunshield human melanoma subtyp data inform biolog comparison canin human melanoma suggest action target speci fund fund provid nih nih gov award number nation institut gov award number stand standuptocanc award number brook blossom hope childhood foundat brookesblossom inc tgen foundat tgen give tgen foundat state genom fund ncsu edu funder role design data collect decis publish prepar compet interest author read polici conflict barbara davi dvm presid ceo innogen inc alter adher plos polici concern data avail melanoma aris transform melanocyt common occur pet dog unlik human melanoma occur sunexpos cutan skin canin melanoma typic aris sunshield oral mucosa canin melanoma clini calli resembl human melanoma particular sunshield subtyp canin melanoma genom remain poor defin similar treatment human melanoma base genom understand improv come patient treatment canin melanoma limit outcom remain poor detail genom basi canin melanoma provid untap potenti improv live pet dog help defin canin melanoma role compar inform human melanoma understand defin genom landscap canin melanoma perform multiplatform characteriza tion tumour integr confirm tumour common mutat canin ortholog human gene ras alongsid mutat pattern share import similar human melanoma type putat ptprj frequent mutat canin melanoma data guid biolog therapeut canin mela noma broad frame util compar canin human cancer introduct human melanoma increas concern cancer rise inci denc fiveyear surviv patient metastat diseas recent remain low dearth curat system therapi discoveri activat ing braf mutat melanoma select inhibitor mutant kinas led dramat respons set metastat diseas brafmut melanoma respond target therapi respons occur brief follow emerg drugresist diseas moreov target ment option melanoma subtyp without activ braf mutat limit paradigm immunotherapi drug combin altern dose strategi circumv resist broaden scope precis mela noma preclin regimen requir robust model recapitul complex tumour featur intratumour genom heterogen tumour host interact meanwhil anim model exist uncommon histolog cal melanoma subtyp braf wildtyp brafwt mucos melanoma plos https pgen compar genom canin malign melanoma naturallyoccur canin cancer increas recognis meet plex model develop gradual amidst interact host stroma immun system spontan canin malign melanoma almost univ salli brafwt mucos subtyp preval clinic signific form fill specif gap model brafwt histolog melanoma subtyp human mucos melanoma aggress histolog subtyp predomin braf ras wild type tripl wild type twt occasion mutat kit nras carri fiveyear surviv rate subtyp limit low preval account human melanoma unit state case hand canin malign melanoma account year diagnos unit state occur common oral mucosa aris cutan acral epithelium canin malign melanoma high preval close mirror human melanoma clini calli patholog extrem aggress median surviv oral case mere day littl genet aetiolog predomi nant brafwt number alter region canin chromosom cfa alongsid myc amplif delet target sequenc though limit infrequ bear alter driver human melanoma ration canin oral melanoma complex number profil chromosom homolog profil human chromosom hsa human mucos melanoma suggest rearrang drive melanoma subtyp despit low preval braf mutat immunohistochemistri ihc mitogenactiv protein kinas mapk phosphoinositid pathway activ case data hint under mutat drive pathway guid futur biolog explor therapeu tic canin human diseas set map genom landscap canin melanoma use combina tion massiv parallel whole sequenc wgs arraybas platform tar gete sequenc identifi somat chang drive cancer report identif recurr inactiv mutat candid tumour suppressor ptprj addit ras mutat mutuallyexclus alter ation therebi defin genom landscap cancer identifi similar melanoma subtyp speci highlight subtypespecif aberr use guid futur result pattern mutat identifi whole canin melanoma undertook comprehens acquir genet alter discoveri cohort melanoma match germlin dog tumour deriv use wgs detect subtl sequenc alter alongsid longinsert wgs liwg materi method sensit detect structur variant perform number target analys addit canin malign melanoma tumour canin malign melanoma line snapfrozen tumour primari tumour except acral metastasi match whole blood lect iacucapprov protocol andel institut vari plos https pgen compar genom canin malign melanoma genom analys perform canin melanoma platform type alter detect sampl analys discoveri cohort wgs liwg mrnaseq acgh snpa preval cohort target sequenc snpa total distinct sampl point mutat number structur alter number structur alter express point mutat transcript abund number alter number alter point mutat number alter tumour match normal sampl tumour match normal sampl line tumour sampl match normal line wgs whole sequenc insert mrnaseq messeng rna sequenc acgh array compar genom hybrid snpa singl nucleotid polymorph array https pgen dog undergo surgeri specialti veterinari clinic locat state materi method diagnosi melanoma confirm independ boardcertifi veterinari pathologist onsit pathologist addit stain mela nocyt differenti marker tissu sampl indic divers breed repres cohort enrich cocker spaniel golden retriev dog breed equal ratio male femal dog median age resect year clinicopatholog characterist cohort wgs liwg respect median fold sequenc coverag physic coverag achiev read align perform use canin refer canfam stringent use somat sequenc variant intersect seurat strelka mutect materi method total somat singl nucleotid variant snvs small insert delet indel median genomewid snvs rang indel rang median mutat rate mutat callabl haploid megabas rang genomewid snv spectrum show transit preval median total snvs follow transit median transvers median despit preval transit occur cpg dinucleotid enrich dipyrimidin median canon signatur pres ent case addit look tert promot muta tion report human cutan melanoma associ damag somat mutat within kilobas tert transcript site common mutat gcg trinucleo tide median follow acg median tct median evid localis hypermut kataegi identifi tumour plos https pgen compar genom canin malign melanoma wholegenom canin melanoma discoveri cohort sampl inform sampl tumour type breed gender age diagnosi mucos mucos mucos mucos mucos acral cutan snvs snv indel cnvs mut rate cnv cnv amp svs ctx inv dup snv somat singl nucleotid variant indel insert delet mut rate mutat rate snvs indel callabl cnv somat number variant cnv percentag involv cnvs amp amplificationlog ratio deletionlog ratio somat structur variant ctx interchromosom transloc inv invers delet dup duplic english cocker spaniel labourador retriev cocker spaniel femal male https pgen somat code mutat identifi canin melanoma tumour assess wholegenom display abund somat structur vari ant svs number variant cnvs modest burden snvs code region landscap somat mutat full cohort tumour base multiplatform circo plot depict somat alter tumour discoveri cohort genomewid snvs median nonsynonym singlebas substitut indel occur within cod ing region nssnvs rang median nonsynonym synonym mutat ratio rang addit perform rna sequenc cohort align call snvs haplotypecal gatk utilis igv manual valid express sequenc variant materi method ninetyseven percent nssnvs identifi wgs genotyp sequenc ing platform confirm addit platform number mutat ortholog human gene singl tumour gene includ hras kit kras nras recurr snvs discov eri cohort gene mutat case ptprj ptrpj valid multipl platform case case contain somat ptprj mutat mucos putat contain hit determin preval mutat panel gene whose ortholog play role human melanomagenesi well ptprj mutat case perform target sanger sequenc proteincod region braf gnaq kit kras mitf nras pten ptprj expand cohort braf gnaq mitf univ salli wildtyp putat pathogen mutat discov kit kras nras pten ptprj somat number structur variant identifi canin melanoma somat cnvs discoveri cohort identifi shortinsert whole sequenc siwg use establish method materi method median plos https pgen compar genom canin malign melanoma plos https pgen compar genom canin malign melanoma mutat landscap canin melanoma repres circo plot depict code snvs cnvs svs singl mucos melanoma outer circl depict canin chromosom number triangl snvs locat within code region middl circl denot cnvs gain loss aberr amplitud line transect plot show transloc number type code mutat identifi siwg liwg discoveri cohort independ primari tumour integr genom data present canin melanoma canin melanoma line column repres data singl tumour indic tumour type mucos uveal acral cutan display annot recurrentlymut hallmark gene mutat identifi wgs acgh snp array target sequenc present order frequenc recurr cnv region identifi snp array gistic well recurr region involv transloc identifi liwg genom annot tumour legend present bottom https pgen focal cnvs rang focal amplif ratio rang focal delet ratio rang identifi discoveri cohort compris cnvs addit identifi cohort utilis illumina caninehd beadchip singl nucleotid polymor phism snp array agil sureprint canin cgh microarray previous materi method high platform concord cnv expand total melanoma snp array addit case preval cohort alter region assess gistic statist signific frequenc amplitud gscore ten nific region identifi includ loss within cfa well gain gistic region contain gene includ gain ortholog human gene addit driver alter homozyg delet tumour suppressor gene focal amplif onco gene includ homozyg delet kit focal amplif somat svs includ transloc invers duplic identifi discoveri cohort base call delli liwg materi method predict svs identifi tumour median predomi nant invers recurr rearrang notabl alter human ortholog impact svs singl case includ arh invers invers transloc invers transloc invers region somat svs tumour rearrang occur case bore alter region span signifi gistic region cnv svs tumour alter occur within region span encompass gistic region case complex chromosom rearrang reminisc chromothripsi tumour chain clustre breakpoint localis subset chromosom region contain copynumb oscil braf ras kit mutat approxim human cutan melanoma driven part braf ras kit mutat confer constitut mitogen signal mapk pathway alter far common human mucos acral mela noma somat alter braf identifi within platform canin melanoma cohort ras famili member whose protein product predict share sequenc ident human ortholog mon mutat gene aggreg occur case humanconserv hotspot fig nras codon kras codon mutat plos https pgen compar genom canin malign melanoma recurr somat alter canin melanoma distribut ras mutat within cohort sampl recurr amplifi region tumour defin minim region surround locat potenti deleteri mutat putat tumour suppressor ptprj sanger sequenc code sequenc tumour individu mutat locat within https pgen occur case singl case bore hras mutat total ras mutat acral cutan case bore nras kras mutat mucos case bore nras kras hras mutat number loss occur case homozyg delet truncat mutat identifi kit mutat cutan mucos tumour plos https pgen compar genom canin malign melanoma tabl cutan case mutat result glutamin arginin chang codon notabl site variat canin human ortholog chang predict damag provean constitut germlin snp germlin dna case kit mutat mucos case includ infram delet amino acid like damag mutat common mutat region human ortholog well aspart acid valin chang codon correspond common hotspot mutat occur kinas domain kit human cancer number gain encompass ing kit sampl mucos acral cutan jone focal amplif identifi ptprj mutat common mutat cohort putat tumour suppressor ptprj previous inactiv point mutat fig ptprj densityenhanc phosphatas pro tein tyrosin phosphatas receptor origin discov virtu overexpress dens cultur human lung fibroblast sinc frequent involv allel loss loss heterozygos loh human cancer mous model potenti play role oncogenesi divers type somat homozyg delet truncat mutat yet speci tumour suppressor status remain controversi canin human ortholog share sequenc ident high conserv terminus contain pro tein tyrosin phosphatas catalyt domain near ident speci sequenc ptprj tumour reveal mutat case mucos compris tumour mucos case frameshift gain discov addit splice site mutat ctermin acid delet singl predict damag missens mutat case contain mutat consist putat biallel inactiv tumour suppressor loh evid adjac snps wgs data case bear mutat consist find ptprj frameshift tumour occur allel ratio dna rna final ptprj transcript rnaseq data ptprjmutant tumour profil wgs rnaseq fragment kilobas transcript mil lion map read fpkms fpkms contain somat ptprj mutat frameshift splice site muta tion fpkms bore lowest transcript abund profil tumour median ptprj fpkms ptprj wildtyp tumour rang amplif mutat inactiv network critic step tumourigenesi near cancer truncat mutat amplif regul key rout inactiv mutat amplif human melanoma common case cohort canin melanoma bore focal amplif truncat mutat recurr focal amplif identifi whole tumour discoveri cohort extend snp array preva lenc cohort reveal addit tumour bear amplif minim plos https pgen compar genom canin malign melanoma region fig total case bore amplif involv gene like amplif target amplif occur mucos melanoma proxim human canin genom target bipartit amplif alongsid coamplifi case identif focal amplif wgs rnasequenc cohort coincid high transcript abund gene relat wildtyp counterpart fpkms amplifi case relat median rang wildtyp case fpkms amplifi case median rang wildtyp case addit twenti tumour addit assess express ihc case focal amplif show promin stain case lack amplif ihc addit discov tumour mutat whose protein product share ident human ortholog mutat truncat ing homozyg heterozyg heterozyg missens mutat predict damag occur tumour singl tumour mutat confirm somat match germlin dna codon canin homolog codon human fifth hotspot mutat human missens variant like snp occur tumour match germlin dna unavail predict neutral previous keep find cancer sequenc mutat amplif mutual exclus mutat alter mutual exclus ras mutat case pathway dysregul canin melanoma common genom subtyp human cutan melanoma braf ras case engaug oncogen signal mapk pathway common human noncutan melanoma canin malign melanoma case undertak unbiass identif pathway contribut canin melanomagenesi perform pathway use wgs data discoveri cohort generat gene bear nonsynonym mutat lie within chromosom breakpoint signific cnv region gistic order determin enrich ment mutat gene within specif kegg reactom pathway materi method network affect gene identifi pathway signifi benjaminihochberg correct pvalu signific enrich pathway insulin receptor substrat mediat signal irsrel event gene pathway member mutat cohort notabl pathway converg mapk mitogen signal core pathway mem ber fgfs hras kras nras rptor inde major enrich pathway member mapk growth receptor signal cascad mtor signal signal rho gtpase vegf signal raf activ melanoma signal ras nale mek activ mani case intersect signal plos https pgen compar genom canin malign melanoma melanoma clinic signific diseas dog hold untap poten tial develop approach live pet dog inform human melanoma option local advanc metastat canin melanoma part aetiolog larg unknown similar limit understand sunshield brafwt type human melanoma constrain innov order identifi molec ular alter under canin melanoma undertook comprehens multiplatform genom integr confirm tumour driven mutat landscap distinct human cutan melanoma share import similar brafwt histolog subtyp human melanoma data guid biolog therapeut canin melanoma lend support use natur occur canin model compar human cancer build cytogenet landscap canin melanoma provid comprehens view number type somat code mutat cer dearth genom data canin melanoma focus collect primari tumour divers breed suffici power draw conclus breed associ somat mutat nonetheless import potenti associ breed somat mutat landscap particu lar associ occur canin cancer lym phoma sever breed suggest increas risk malign melanoma particular breed heavili pigment skin oral mucosa cocker spaniel schnauzer scottish terrier poodl chow chow golden retriev wgs discoveri cohort primarili consist cocker spaniel cocker spaniel english cocker spaniel labrador breed report higher risk oral mela noma extend cohort includ target sequenc melanoma hallmark gene well ptprj addit recurr mutat wgs cohort number assess snp array total breed wgs cohort predomin cocker spaniel recurr breedsp cific somat snvs nonmelanomahallmark gene exist captur futur expand breedspecif cohort critic understand role germlin variat shape somat landscap speci import defin subtyp differ expand cohort canin acral cutan tumour well benign precursor lesion genom landscap human melanoma vari anatom site degre sun exposur cutan sunexpos melanoma characteris high point mutat frequenc link damag modest burden struc tural variat contrast sunshield noncutan melanoma harbour low point mutat high structur mutat burden canin malign melanoma landscap resembl report human sunshield melanoma canin melanoma subtyp discoveri cohort like sunshield includ cutan tumour occur dens hairbear skin crop shave summer month case exposur keep status wgs canin cutan malign melanoma case provid deep view genomewid mutat burden reveal low point mutat frequenc median somat mutat human acral mucos melanoma wgs data hayward profil case plos https pgen compar genom canin malign melanoma plos https pgen compar genom canin malign melanoma key deregul pathway canin human melanoma mutat rate canin human melanoma subtyp somat snvs dna base wgs discoveri cohort compar wgs data human cutan acral mucos melanoma hayward canin mucos human acral human mucos human cutan melanoma orang dot plot repres individu acral cutan subtyp respect discoveri cohort fraction copynumberalt canin melanoma human melanoma sequenc cohort total number structur variant identifi canin human melanoma sequenc cohort transit major melanoma type dipyrimidin nondipyrimidin frequenc mutat key melanoma pathway full cohort mucos tumour compar wgs subtyp hayward https pgen larger cohort need low point mutat burden relat human sunexpos mela noma potenti bear expect respons immunotherapi chequepoint blockad numer correl mutat burden abund neoantigen benefit human mela noma cancer nonetheless determin immunotherapi exist beyond simpli mutat burden activ agent canin malign melanoma remain determin notabl cnv burden wgs canin malign melanoma mark lower subtyp hayward wgs addit provid deep view genomewid mutat signatur high point mutat burden sunexpos cutan melanoma result induc overrepresent transit occur dipyrimidin nondipyr imidin uvinduc mutat occur dipyrimidin compris low proport total snvs cohort reflect human sunshield cutan mucos acral melanoma contrast occur dipyrimidin human sun expos melanoma lend support nonuv aetiolog canin melanoma genomewid snv spectrum reveal transit cpgs common sequenc alter mutat correl age human cancer spontan deamin enrich mutat canin melanoma surpris largest risk cer human dog biolog chronolog age age dog surgic resect year rang relat averag number human somat mutat data provid evid incid mutat burden increas biolog chronolog age common mutat pattern human melanoma kataegi tumour exhibit clustre chain transloc suggest breakagefusionbridg event telomer crisi chromothripsi chromosom undergo punctuat shatter reassembl event event link poor human melanoma enrich tumour dysfunct lack extend telomer notabl show mutual exclus alter common canin melanoma similar inactiv mutat human mucos acral melanoma suggest pathway dysregul crucial nonuv induc melanoma develop ment uvinduc tert promot mutat common human cutan mel anoma sunshield subtyp subtyp bear enrich type mutat drive tert overexpress svs cnvs cutan tumour cohort bear somat tert promot mutat genet lesion enabl telomer extens telo mere crisi surviv structur aberr genom play signific role aetiolog canin melanoma plos https pgen compar genom canin malign melanoma comprehens canin melanoma reveal canin melanoma bear low code mutat burden structur complex human melanoma wgs approach coupl arraybas platform enabl deep interrog chang complement cytogenet analys tumour type signific number gain report defin signatur lesion recapitul dataset multiplatform abl elucid complex chromosom rearrang region region involv multipl intra interchromosom structur event cohort addit focal amplif region encom pass drive human cancer current explor drug target wild type tumour cnvs associ canin melanoma includ gain loss statist signific via gistic cohort event individu sampl extens number structur variat high level largescal chromosom instabl gain loss whole chromosom chromosom arm intrigu mutual exclus focal amplifica tion inactiv mutat enrich braf nras human melanoma human melanoma tend display higher mutat burden presenc transit high degre structur complex lack tert mutat bar putat transloc telomerelengthen mechan frequenc mutat chromosom instabl play key role canin melanomagenesi discoveri cohort putat pathogen somat mutat ortholog human gene singl tumour includ hras kit kras nras melanoma hallmark gene evalu preval cohort includ ptprj addit putat pathogen somat mutat identifi gene nras ptprj kit kras discoveri preva lenc analys ras famili member gene common bear somat snvs occur case fig follow ptprj mutat case kit pten combin mutat common prolif cycl apoptosi pathway pattern display key iti differ human melanoma subtyp despit absenc braf lower abund ras kit mutat canin human mucos melanoma tumour display like mapk activ event case fur ther canin mucos melanoma higher burden cycl apoptot event subtyp hayward compar human melanoma cohort assess larg enrich mutual exclus mutat canin muco sal melanoma mutat common human cutan melanoma rang ing case hayward compar cohort tcga cutan melanoma differ like small size cutan human canin melanoma cohort greater resolut particu lar differ anatom site canin mucos case origin oral caviti human mucos parat larg vulvar nasal caviti ongo exist broader profil melanoma subtyp anatom site find ing nonetheless mapk pathway inhibit via mek inhibitor pathway inhibit via inhibitor import therapeut axe develop ment canin melanoma human plos https pgen compar genom canin malign melanoma oncogen mapk pathway critic import mani cancer central role convey extracellular signal nucleus order regul hallmark includ ing prolifer invas metastasi angiogenesi major human cutan melanoma driven part constitut activ mapk pathway muta tion gene braf nras kit gnaq mutual exclus pattern high frequenc mutat motiv tcga classif tumour mapk mutat status braf case ras twt genom categori correl patho logic biolog featur melanoma compris distinct type common histolog subtyp melanoma mucos acral uveal melanoma bear uniqu mutat spectra uniform centr canon activ mutat mapk pathway correspond braf mutat exceed predomin oral canin malign melanoma date alter mapk member discov find reca pitul cohort show canon braf mutat nonetheless mapk signal activ near case addi tional mutat impact mapk pathway includ kit mutat pten mutat mutat total mucos canin melanoma bear alter impact mapk pathway fig prior mutat under activ remain larg unknown show absenc somat braf mutat snvs cnvs transloca tion encompass braf locus canin malign melanoma keep prior uncov truncat snvs homozyg delet higher proport cohort bear ras mutat previous prior focus almost exclus nras exon major ras famili member high conserv protein iden titi canin human human famili member malign melanoma predomin bear nras mutat kras hras mutat cohort nras codon alter kras mutat hras mutat ras alter nras kras hras mutat occur mucos tumour frequenc subtyp cohort acral tumour cutan tumour detect ras alter kras nras mutat unusu pattern ras mutat canin mela noma reflect import differ biolog tissu speci specif ras famili member data point genom lesion under mapk activ stantial proport canin melanoma subtl genet differ diseas subtyp within speci strike discoveri putat tumour suppressor ptprj receptortyp protein tyrosin phosphatas genet function implic genet mechan inactiva tion yet definit role canon tumour suppressor ptprj sist extracellular domain fibronectin motif transmembran domain intracellular catalyt domain origin clone hela cell charact ize overexpress hyperactiv dens cultur fibroblast regul contact inhibit role regul prolifer invas earli genet quantit trait loci mous suscept homolog region human cancer point recurr ptprj delet loh sens mutat small cohort colourect lung breast carcinoma plos https pgen compar genom canin malign melanoma addit correl ptprj loh colourect progress addit sequenc larger cohort identifi nonsynonym snps extracellular fibronectin repeat associ risk develop thyroid colourect head neck squamous esophag cancer recent subclon missens mutat noncatalyt cytoplasm domain ptprj identifi primari breast tumour signific enrich brain metastas patient deriv xenograft ptprj substrat mediat tumour suppress potenti includ akt receptor tyrosin kinas src kinas ever ptprj knockout mice normal predisposit inactiv appear suffici induc tumourigenesi tcga publish date case tumour type tcga pancanc atlas access via cbioport frequenc somat ptprj point mutat deep delet low somat ptrpj mutat tcga human cutan melanoma data set consist case singl homozyg delet truncat mutat fifteen missens mutat relat receptortyp protein tyrosin phosphatas ptprd thought play role regul signal frequent implic tumour suppressor human cer inactiv somat mutat focal delet methyl glioma mela noma neuroblastoma colourect liver head neck lung cancer human cutan melanoma ptprd delet truncat cutan case determin occur high frequenc histolog subtyp report recurr somat truncat mutat ptprj natur occur discov case canin melanoma bear ing somat ptprj mutat canin human ptprj ortholog share sequenc iden titi high conserv cterminus contain protein tyrosin phosphatas catalyt domain sequenc ptprj tumour reveal mutat case mucos uveal compris tumour mucos case frameshift gain discov addit splice site mutat ctermi nal acid delet singl predict damag missens mutat case contain mutat consist biallel inactiva tion tumour suppressor loh evid adjac snps wgs data case bear mutat region loh chromosom snp array case bear singl mutat ptprj region direct overlap code region ptprj enrich ptprj truncat mutat canin malign melanoma bear intrigu implic previous underappreci role human melanoma asyet understudi role hemizyg delet epig netic modif possibl uniqu mechan tumourigenesi speci deep integr genom combin wgs liwg rna sequenc acgh snp array target sanger sequenc determin canin mela noma driven dysregul mapk cycl apoptosi pathway case wgs cohort predomin cocker spaniel extens chromo somal instabl keep prior compar melanoma incorpor histolog target sequenc acgh highlight strike resembl canin malign melanoma brafwt subtyp human melanoma final addit discov putat tumour suppressor reflect uniqu speciesspecif highlight tumour suppress axei subt alter asyet underappreci human melanoma bear immedi plos https pgen compar genom canin malign melanoma relev improv diagnost approach canin malig nant melanoma provid evid credenti natur occur canin melanoma model relev genom subset human melanoma materi method ethic statement sampl obtain institut protocol andel insti tute collabour local special veterinari clinic protocol sampl histopatholog sampl assess tumour whole blood obtain dog recruit veterinari specialti centr state vari iacuc ethi cal protocol materi collect surgeri snap frozen optim cut temperatur oct compound patient match control dna obtain peripher blood mononuclear cell resect tumour evalu onsit board certifi veterinari pathologist estim tumour content extent tissu heterogen diagnosi malign melanoma histolog confirm defin veterinari pathologist addit recent establish compar analys canin human melanoma focus architectur pigment presenc differenti marker immunohistochemistri tissu microarray tmas design mel tma mel tma consist individu dog tissu sampl place duplic tissu sampl place quadrupl array spot multipl tumour dog array multipl sampl vari site within tumour twelv dog addi tional nonmelanoma stromal control normal tissu includ tmas hematoxi lin eosinstain evalu via routin immunohistochem procedur melanoma cocktail antimelan antimelanosom antityrosinas antibodi vimentin sampl score stain confirm stain melanoma cocktail reevalu stain stain count duplic sampl evalu melanoma cocktail tma antibodi purchas santa cruz biotechnolog marqu total dog spot sampl tumour evalu protein express ihc dog dog melanocyt tumour posi stain spot sampl stain predomin cyto plasmic highest intens junction epitheli subepitheli submucosa dermi stain malign pigment amelanot melanoma benign mela nocytoma intens stain cytoplasm nuclear benign cutan ous melanocytoma boxer addit malign melanoma stain array multipl cutan mast tumour nucleic acid extract tumour tissu blood tissu disrupt homogenis buffer rlt plus qiagen allprep dna rna mini kit use bullet blender next advanc transfer microcentrifug tube contain buffer rlt plus stainless steel bead rnase free stainless steel bead blood leukocyt buffi coat isol whole blood plos https pgen compar genom canin malign melanoma centrifug room temperatur resuspend buffer rlt plus sampl homogenis centrifug full speed lysat transfer qiagen allprep spin column genom dna rna purifi manufactur protocol dna quantifi use nanodrop spectrophotometr qualiti access absorb ratio rna analys agil bioanalys rna nano chip valid rna integr rin librari construct next generat sequenc genom dna sampl fragment target size base pair overhang fragment sampl repair adenin base ligat dilut pair illumina adapt ligat onto atail product ing ligat sampl run tae gel separ product ligat product select sampl isol gel punch purifi phu sion highfidel pcr master mix finnzym catalogu use perform pcr enrich product enrich pcr product run tae gel extract product quantifi use agil high sensit dna chip catalogu agil bioanalys catalogu insert whole librari construct previous modif input use dna fragment bead puri ficat perform sampl bead ratio size select gel use librari enrich pcr cycl use librari clustre onto illumina flowcel san diego use illumina truseq clustr kit sequenc pair read use illumina truseq sbs kit illumina hiseq total rna use generat whole transcriptom librari rna sequenc use nugen ovat rnaseq system total rna use generat doubl strand cdna amplifi use nugen spia linear amplif process amplifi cdna input illumina truseq dna sampl prepar kit set librari prepar amplifi cdna frag ment target insert size repair sampl adenyl index pair adapt ligat ligat product run tae gel size select ligat product isol gel punch purifi clean ligat product input pcr enrich librari pcr product clean quantifi use agil bioanalys tumour normal librari prepar pair sequenc clustr generat use illumina cbot hiseq pair clustr generat kit catalogu sequenc illumina hiseq use illumina hiseq sequenc kit catalogu next generat sequenc data informat tool version flag bcl fastq file convers perform use illumina bcl convert tool read align perform bwa burrowswheel align use canin refer canfam align bam indel insert delet realign recalibr use gatk duplic read mark use picard broadinstitut github picard variant call use strelka seurat mutect call annot dbsnp snps illumina cani nehd beadchip final somat snvs call caller plos https pgen compar genom canin malign melanoma liwg data utilis cnv detect cnv detect read depth everi base sequenc region determin next normalis fold chang tumour normal calcul smooth window tumour allel frequenc heterozyg germlin snps utilis evalu potenti fals posit correct bias final circular binari segment algorithm use correct foldchang mutat burden metric focal cnv includ chang detect perform utilis delli minimum tumour allel ratio minimum qualiti score requir call rna sequenc data fastq format cheque qualiti use cyclebycycl iti plot bias content read align canin refer canfam use generat align file bam format somat snvs call haplotypecal gatk verifi igv transcript abund fpkms fragment kilobas transcript million map read obtain cuffdiff annot use ensembl canfam data next generat sequenc data submit ncbi biosampl databas ncbi nlm nih gov bioproject project number sampl access pathway gene singl nucleotid variat structur variat number variat discoveri cohort analys use cytoscap plugin creat function organis pathway network kappa score use measur associ network function network creat minimum kappa score threshold minimum affect gene everi network form total associ gene particular network gene assign network base predefin pathway kegg reactom wiki pathway pathway obtain benjaminihochberg correct pvalu pathway group base interterm kappa score name nific pathway respect group pcr amplif sanger sequenc pcr amplif gene nras kras braf gnaq ptprj pten ckit mitf perform use primer target code exon amplif reaction perform use platinum taq dna polym ase life technolog carlsbad briefli primer pair mix genom dna subject cycl parametr cycl temperatur sec sec sec cycl sec sec sec final extens pcr amplicon sequenc use forward revers primer arizona state dna lab temp array compar genom hybrid oligo array cgh acgh perform cohybrid tumour test dna refer dna sampl latter compris equimolar pool genom dna plos https pgen compar genom canin malign melanoma sampl multipl healthi individu breed dna label use agi lent suretag label kit agil technolog santa clara test sampl label common refer sampl label fluo rochrom incorpor final probe concentr determin use routin spec trophotometr parametr read fluoresc label test refer sampl cohybridis canin featur cgh array agi lent amadid rpm previous array scan use highresolut microarray scanner agil model data extract use featur extract softwar scan data assess iti qualiti metric report agil featur extract softwar agil technolog snp array genotyp snp genotyp perform use illumina caninehd array manufactur protocol dna denatur neutralis naoh amplif hour amplifi dna enzymat frag ment precipit use dri hour room tempera ture resuspens fragment dna denatur load onto caninehd beadchip hybridis hour beadchip wash singl base extens hybridis primer follow multilay stain primer array wash coat reagent illumina dri vacuum hour coat array read hiscan system data visualis use illu genomestudio genotyp softwar averag sampl rate acgh snp array data acgh snp array number data analys nexus number softwar biodiscoveri inc crossplatform comparison liwg bam analys utilis nexus softwar cnvs identifi use segmenta tion algorithm signific threshold aberr defin mini mum consecut probe tumour refer valu high gain gain loss big loss recurr cnvs within subtyp determin within nexus use involv threshold signific region determin nexus use gistic algorithm identifi region statist high frequenc cnvs background gscore cut signific cnv frequenc comparison amongst sampl group perform nexus use fisher exact test differenti threshold signific signific probe group calcul nexus use mann whitney test median support inform histopatholog featur canin malign melanoma hematoxylin eosin stain subtyp canin melanoma includ magnif magnif canin mucos melanoma canin acral melanoma canin cutan melanoma tif extend trinucleotid mutat spectrum distribut somat singl nucleotid mutat type discoveri cohort total snvs dinucleotid context plos https pgen compar genom canin malign melanoma transit dipyrimidin nondipyrimidin discoveri cohort muta tional signatur base trinucleotid context frequenc somat singl nucleotid mutat discoveri cohort tif circo plot display genom landscap canin melanoma outer ring compris chromosom karyotyp snvs adjac intern track triangl cnvs display inner ring show gain loss rearrang display line connect loci tif cnv concord plot platform discoveri cohort tif align human canin kit queri repres human protein access number compar subject canin protein share ident protein tif align human canin ptprj queri repres human protein access number compar subject canin protein share ident protein indic high conserv protein tyrosin phosphatas catalyt domain tif rnaseq fragment kilobas transcript million map read fpkms tif stain canin melanoma repres sampl canin mel anoma tma stain show increas express sampl mag nific cytoplasm stain highest intens junction epitheli subepitheli layer arrow tif align human canin queri repres human protein access number compar subject canin protein share ident protein tif frequenc ptprj mutat human cancer spectrum ptprj alter within sampl cbioport distribut report ptprj sequenc mutat cbioport tif canin melanoma sampl inform data wgs whole sequenc insert mrnaseq mrna sequenc snpa singl nucleotid polymorph array xlsx whole sequenc metric averag number time base read span mate pair read calcul use formula physic coverag number align read read multipli denot pair sequenc size canin interread base pair distanc seqenc proport genotyp accur minimum plos https pgen compar genom canin malign melanoma read depth singl locus pass philtr xlsx somat code mutat identifi canin melanoma discoveri cohort sequenc approach includ next generat sequenc shortinsert wholegenom siwg longinsert whole liwg mrnaseq sanger sequenc sanger valid uninform read detect locus data xlsx somat nssnvs indentifi target sanger sequenc canin melanoma predict deleteri provean provean jcvi index php associ germ unavail annot use refseq ensembl posit base build xlsx somat number alter identifi canin melanoma discoveri cohort xlsx number variat identifi snp array gistic canin mela noma xlsx number variat identifi snp array canin melanoma sampl xlsx somat structur variant identifi canin melanoma discoveri cohort xlsx loh identifi snp array canin melanoma sampl xlsx amplif immunohistochemistri xlsx signific dysregul pathway canin melanoma xlsx ptprj mutat human cancer xls informat tool version flag xlsx acknowledg thank antonneia pritchard valu input genom analys contribut conceptu william hendrick victoria zismann karthigayini sivaprakasam winni liang alison ruhe nichola duesberi matthew breen alexand sekul jef frey trent data curat william hendrick victoria zismann karthigayini sivaprakasam christoph legendr waibhav temb niev perdigon jeffrey kiefer winni liang plos https pgen compar genom canin malign melanoma mitchel stark alison ruhe roe froman nichola duesberi megan washingtonn jes sica aldrich mark neff matthew huentelman nichola hayward kevin brown dougla thamm gerald post chand khanna barbara davi matthew breen alexand sekul jeffrey trent formal william hendrick victoria zismann karthigayini sivaprakasam christoph legendr waibhav temb niev perdigon jeffrey kiefer winni liang megan washingtonn jessica aldrich mark neff matthew breen fund acquisit william hendrick jeffrey trent william hendrick victoria zismann karthigayini sivaprakasam chris toph legendr kelsey poorman waibhav temb niev perdigon jeffrey kiefer win nie liang valeri deluca megan washingtonn jessica aldrich mark neff matthew breen alexand sekul jeffrey trent methodolog william hendrick victoria zismann karthigayini sivaprakasam chris toph legendr mitchel stark nichola hayward kevin brown dougla thamm gerald post chand khanna barbara davi project administr william hendrick victoria zismann matthew breen alexan sekul jeffrey trent resourc william hendrick victoria zismann karthigayini sivaprakasam alison ruhe roe froman nichola duesberi matthew huentelman matthew breen jeffrey trent softwar william hendrick victoria zismann karthigayini sivaprakasam christoph legendr waibhav temb jeffrey kiefer winni liang megan washingtonn matthew breen supervis william hendrick victoria zismann matthew breen jeffrey trent valid william hendrick victoria zismann karthigayini sivaprakasam nichola hayward kevin brown visualis william hendrick victoria zismann karthigayini sivaprakasam chris toph legendr waibhav temb niev perdigon jeffrey kiefer winni liang megan washingtonn matthew breen write origin draught william hendrick victoria zismann karthigayini sivaprakasam write edit william hendrick victoria zismann karthigayini siva prakasam niev perdigon matthew breen alexand sekul jeffrey trent refer siegel jemal statist clinician pollock harper hansen yudt stark robbin high frequenc braf mutat nevi https pmid chapman hauschild robert haanen ascierto larkin improv surviv vemurafenib melanoma braf mutat england https pmid davi bignel cox stephen edkin clegg mutat braf human https pmid plos https pgen compar genom canin malign melanoma sun huang heynen prahallad robert revers adapt resi tanc braf inhibit melanoma https pmid flaherti robert hersey nathan garb milhem improv surviv mek inhibit brafmut melanoma england https pmid flaherti infant daud gonzalez kefford sosman combin braf mek inhibit melanoma braf mutat england https pmid hodi mcdermott weber sosman haanen improv surviv ipilimumab patient metastat melanoma england https pmid thakur salangsang landman seller pryer levesqu model vemurafenib resist melanoma reveal strategi forestal drug resist https pmid khanna fan gorlick helman kleinerman adamson toward drug devel opment path target metastat progress osteosarcoma https pmid paoloni khanna translat treatment pet dog human review https pmid tang lyon camp daltonn rie driver passeng distinct via spo radic human proofofprincipl colourect oncogen https onc pmid liu xiong elli northrup rodriguez regan homolog dif ferenc spontan canin mammari human breast https pmid bushel chan benneriah jenk alcaid genet inactiv canin human bcell lymphoma blood https blood pmid schiffman breen compar oncolog dog speci teach human phil tran soc leblanc breen choyk dewhirst fan gustafson perspect best friend nation workshop compar oncolog sci transl https scitranslm pmid manolidi donald malign mucos melanoma head neck pmid meleti leeman bree vescovi sesenna waal head neck mucos melanoma experi patient emphasi role postop radiotherapi head neck tanaka yamada tanaka shimizu oka editor diagnosi mela noma engin societi iemb intern confer enc ieee curtin busam pinkel bastian somat activ kit distinct subtyp melanoma oncolog https jco pmid maldonado fridlyand patel jain busam kageshita determin braf mutat primari melanoma nation institut pmid curtin fridlyand kageshita patel busam kutzner distinct set genet alter melanoma england https pmid turajl furney lambro mitsopoulo kozarewa geyer whole sequenc match primari metastat acral melanoma res https pmid krauthamm kong evan bacchiocchi mccusker exom sequenc identifi recurr somat mutat melanoma https pmid plos https pgen compar genom canin malign melanoma furney turajl stamp nohadani carlisl thoma sequenc mucos melanoma reveal driven distinct mechan cutan melanoma patholog https path pmid hayward wilmott waddel johansson field none wholegenom land scape major melanoma subtyp https pmid chang karnel menck nation data base report cutan noncuta neous melanoma pmid cotchin melanot tumour dog compar patholog therapeut smith goldschmidt mcmanus compar melanocyt neoplasm veteri nari patholog villamil henri bryan ellersieck schultz tyler identif cutan neoplasm dog evalu breed age distribut select neo plasm veterinari associ https javma pmid bergman canin oral melanoma techniqu small anim practis https ctsap pmid gillard cadieu brito abadi vergier devauchell natur occur melano dog model nonuv pathway human melanoma pigment melanoma prasad patel huvo shah busam primari mucos melanoma head neck https cncr pmid bergman wolchok mice dog xenogen dna vaccin canin oral malign melanoma ther bergman kent fares melanoma withrow macewen small anim oncolog withrow vail loui saunder simpson bastian michael webster prasad conway sporad natur occur melanoma dog preclin model human melanoma pigment melanoma shelli chien yip kent thaeon mccallan exon braf mutat uncommon canin oral malign melanoma mammalian https pmid fowl dentonn gustafson compar mapk akt pathway activa tion inhibit human canin melanoma veterinari compar oncolog https vco pmid murakami mori sakai murakami yanai hoshino kit express kit exon mutat canin oral malign melanoma veterinari compar oncolog https pmid chu pan liu yeh liao kit exon mutat canin malign melanoma veterinari https tvjl pmid poorman borst moroff roy labell motsingerreif compar cytogenet character primari canin melanocyt lesion use array cgh fluoresc situ hybrid chromosom https pmid spring lapoint caron langloi royal phosphoryl ptprj thraeonin regul src activ endotheli permeabl induc vascular endotheli growth signal https cellsig pmid liang aldrich temb kurdoglu cherni phillip insert whole sequenc number variant transloc detect nucleic acid https nar pmid smedley lamoureux sledg kiupel immunohistochem diagnosi canin oral amela notic melanocyt neoplasm veterinari patholog berger hodi heffernan derib lawrenc protopopov melanoma sequenc reveal mutat https pmid plos https pgen compar genom canin malign melanoma alexandrov nikzain wedg aparicio behjati biankin signatur muta tional process human https pmid huang hodi kryukov chin garraway high recurr tert promot mutat human melanoma https pmid nikzain alexandrov wedg loo greenman rain mutat pro cess mould genom breast cancer https pmid dobin davi schlesing drenkow zaleski jha star ultrafast univers rna seq align bioinformat jan https bioinformat pmid stark hayward genomewid loss heterozygos number melanoma use highdens singlenucleotid polymorph array https pmid mermel schumach hill meyerson beroukhim getz facilit sensi confid local target focal somat copynumb alter human cancer biol https pmid rausch zichner schlattl stu bene korbel delli structur variant discoveri integr pairedend splitread bioinformat https bioinformat pmid stephen greenman bignel mudi massiv genom rearrang ment acquir singl catastroph https pmid hodi watson kryukov arold imielinski theurillat landscap driver mutat melanoma https pmid furney turajl stamp nohadani carlisl thoma sequenc mucos melanoma reveal driven distinct mechan cutan melanoma patholog https path pmid furney turajl stamp thoma hay strauss mutat burden acral melanoma reveal wholegenom sequenc compar pigment mela noma liang hendrick kiefer schmidt sekar carpten integr genom analys reveal tert aberr acral melanoma res https pmid choi sim murphi miller chan predict function amino acid substitu tion indel https pone pmid forb bear gunasekaran leung bindal boutselaki cosmic explor somat mutat human nucleic acid ostman tonnek express receptorlik proteintyrosinephosphatas enhanc increas densiti proceed nation scienc ruivenkamp wezel zanon stassen vlcek csiko ptprj candid mous coloncanc suscept locus frequent delet human cancer https pmid ruivenkamp hermsen postma klous baak meijer loh ptprj occur earli colourect associ chromosom loss oncogen https onc pmid lesueur pharoah ahm jordan smith allel associ human homologu mous modifi ptprj breast human https hmg pmid godfrey arora bauer stopp ller heinrich transform itd acut myeloid leukaemia oxid inactiv tumour suppressor proteintyrosin phos phatas ptprj blood https blood pmid plos https pgen compar genom canin malign melanoma trapasso drusco costinean alder aqeilan iuliano genet ablat ptprj mous suscept result normal growth predispos spontan tumourigenesi dna https dna pmid petermann haas wetzel balavenkatraman tenev hrs loss pro teintyrosin phosphatas ptprj drive meningioma motil brain patholog https pmid mita yasuda sakai yamamoto toyooka gunduz missens polymorph ptprj gene suscept varieti human cancer oncolog https pmid iuliano palmieri iervolino borbon pallant role ptprj genotyp papil lari thyroid carcinoma risk endocrinerel https pmid gaudio costinean raso mangon paduano zanesi tumour suppressor activ ptprj receptortyp protein tyrosin phosphatas human melanoma cell iuliano pera cristofaro baudi arturi pallant tyrosin phosphatas ptprj dep genotyp affect thyroid carcinogenesi oncogen https onc pmid toland rozek presswala rennert gruber ptprj haplotyp colourect risk epidemiolog biomark prevent vogelstein lane levin surf network https pmid momand zambetti olson georg levin oncogen product form complex protein inhibit transactiv pmid wikman nymark yrynen jarmalait kallioniemi salmenkivi proba target amplicon lung gene chromosom cer https gcc pmid reifenberg ichimura reifenberg elkahloun meltzer collin refin map amplicon human malign glioma suggest sas indepen dent amplif target pmid vayss ratnakumar derrien axeelsson rosengren pielberg sigurdsson identifi cation genom region associ phenotyp variat breed use selec tion map plos genet https pgen pmid axeelsson ratnakumar arendt maqbool webster perloski genom domest reveal adapt starchrich diet https pmid lindbladtoh wade mikkelsen karlsson jaff kamal sequenc compar haplotyp structur domest https pmid bindea mlecnik hackl charoentonneg tosolini kirilovski cluego cytoscap plugin decyph function group ontolog pathway annot network bioinformat https bioinformat pmid kanehisa goto sato furumichi tanab kegg integr interpret largescal data set nucleic acid croft mundo haw milac weiser reactom pathway knowledgebas nucleic acid elver turnermai swofford koltookian johnson stewart exom sequenc lymphoma breed reveal somat mutat pattern reflect genet background res https pmid dobson breedpredisposit pedigre dog isrn veterinari snyder makarov merghoub yuan zaretski desrichard genet basi blockad melanoma england https pmid plos https pgen compar genom canin malign melanoma postow callahan wolchok immun chequepoint blockad therapi oncolog https jco pmid pleasanc cheetham stephen mcbride humphray greenman prehens catalogueu somat mutat human https pmid tomasetti vogelstein parmigiani half somat mutat cancer self renew tissu origin prior tumour initi proceed nation scienc cohen reif brodey keiser epidemiolog preval site type canin neoplasia veterinari pmid dorn taylor schneider hibbard klauber survey anim neoplasm meda costa counti california morbid dog cat alameda counti nation institut pmid dobson samuel milstein roger wood jln canin neoplasia estim inci denc rate popul insur dog small anim practis pmid merlo rossi pellegrino ceppi cardellino capurro incid pet dog find anim tumour registri genoa vet intern jul undefin https pmid albert benjamin shukla life span mortal beagl human mechan age pmid turker somat mutat provid link age mechan age hirsch kemmerl davi camp meltzer rie chromothripsi focal number alter determin poor malign melanoma https pmid rausch jone zapatka stu zichner weischenfeldt sequenc paediatr medulloblastoma link catastroph dna rearrang mutat maher wilson chromothripsi human diseas piec shatter process vassilev grave carvaj podlaski filipov vivo activ pathway smallmolecul antagonist https pmid network cga genom classif cutan melanoma https pmid duttonneregest brown hayward genom landscap cutan mela noma pigment melanoma simpson bastian michael webster prasad conway sporad natur occur melanoma dog preclin model human melanoma pigment melanoma mochizuki kennedi shapiro breen braf mutat canin cancer plos https pone pmid borg seifert hart distech edelhoff clone characteriza tion rat densityenhanc protein tyrosin phosphatas express vascular cell circul pmid trapasso iuliano boccia stella visconti bruni rat protein tyrosin phosphatas suppress neoplast phenotyp retrovir transform thyroid cell stabilis pmid kean lowrey ettenberg daytonn lipkowitz protein tyrosin phosphatas induc differenti inhibit growth breast cell pmid balavenkatraman jandt friedrich kautenburg poolzobel stman pro tein tyrosin phosphatas inhibit prolifer migrat colon carcinoma cell upregu late protect nutrient oncogen https onc pmid plos https pgen compar genom canin malign melanoma martelli battaglia trapasso tramontano viglietto thyroid transfor mation inhibit express rat protein tyrosin phosphatas https excr pmid trapasso yendamuri dumon iuliano cesari feig restor receptortyp protein tyrosin phosphatas function inhibit human pancreat carcinoma growth vitro vivo carcinogenesi https carcin pmid kovalenko denner sandstro persson gro jandt siteselect dephosphori lation plateletderiv growth receptor receptorlik proteintyrosin phosphatas biolog pmid palka park tonnek hepatocyt growth receptor tyrosin kinas substrat receptor proteintyrosin phosphatas biolog https jbc pmid lampugnani zanetti corada takahashi balconi breviario contact inhibit vegfinduc prolifer requir vascular endotheli cadherin catenin phosphatas https jcb pmid ding elli larson chen walli remodel basallik breast metastasi xenograft https pmid spring fournier lapoint chabot roussi pommey protein tyrosin phospha tase ptprj promot breast invas metastasi oncogen https onc pmid chabot spring grattonn elchebl royal role protein tyrosin phosphatas akt activ endotheli surviv https mcb pmid sacco tinti palma ferrari nardozza huijsduijnen tumour suppressor sityenhanc inhibit ras pathway direct dephosphoryl kinas biolog https jbc pmid arora stopp hmer schon godfrey masson proteintyrosin phosphatas control receptor tyrosin kinas signal biolog https jbc pmid tarcic boguslavski wakim kiuchi liu reinitz unbiass screen identifi tumour suppressor phosphatas control egfr endocytosi current https cub pmid cerami gao dogrusoz gross sumer aksoy cbio genom tal open platform explor multidimension genom data discoveri https pmid gao aksoy dogrusoz dresdner gross sumer integr complex genom profil use cbioport signal veeriah brennan meng singh fagin solit tyrosin phosphatas ptprd tumour suppressor frequent inactiv mutat glioblastoma human cer proceed nation scienc solomon cronin sibenal ryken rosenberg mutat inactiv ptprd glioblastoma multiform malign melanoma https pmid walia prickett gartner lin zhou mutat function tumoursuppressor ptprd human melanoma human mutat https humu pmid nair depret vandesompel speleman stall aberr splice ptprd mimic microdelet identifi locus neuroblastoma gene chromosom https gcc pmid stark wood gartsid bonazzi duttonneregest aoud somat mutat metastat melanoma identifi exom sequenc solimini mermel liang schlabach luo recurr hemizyg delet cancer optimis prolif potenti https pmid plos https pgen compar genom canin malign melanoma goldschmidt histolog classif epitheli melanocyt tumour skin dome tic anim arm forc institut patholog registri patholog orga nizat collabour compar oncolog liang aldrich temb kurdoglu cherni phillip insert whole sequenc number variant transloc detect nucleic acid res jan https nar pmid durbin fast accur read align burrowswheel transform bioinformat epub https bioinformat pmid mckenna hanna bank sivachenko cibulski kernytski toolkit mapreduc framework analys nextgener dna sequenc data res https pmid auwera carneiro hartl poplin angel levymoonshin fastq data highconfid variant call toolkit best practis pipelin cur rent protocol bioinformat saunder swami becq murray cheetham strelka accur somat smallvari call sequenc tumournorm sampl pair bioinformat https bioinformat pmid christoforid carpten weiss demeur hoff craig identif somat mutat bayesianbas sequenc pair genom https pmid cibulski lawrenc carter sivachenko jaff sougnez sensit detect somat point mutat impur heterogen sampl nat biotechnol https nbt pmid cingolani platt coon nguyen programmem annot pre dict effect singl nucleotid polymorph snpeff snps drosophila mel anogast strain fli https fli pmid olshen venkatraman lucito wigler circular binari segment array base dna number data biostatist https biostatist pmid angstadt thayanithi subramanian modiano breen genomewid parat oncolog highresolut oligonucleotid acgh canin human osteosarcoma pin point share microaberr https cancergen pmid thoma borst rotroff motsingerreif lindbladtoh modiano genom profil reveal extens heterogen somat dna number aberr canin hemangiosar coma chromosom https pmid plos https pgen